Mark Egerton

Pharmaceutical Profiles Ltd. develops drugs for pharmaceutical and biotech companies. The company studies how drugs are absorbed and processed in the human body. It utilizes gamma camera imaging products in its studies. It also provides complete scientific, regulatory and medical support for its client's clinical development programs. Pharmaceutical Profiles was founded in 1990 and is headquartered in Nottingham, UK.

Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom.

Incyte Pharmaceuticals, Inc. engages in the provision of biopharmaceutical services. The company was founded in April, 1991 is headquartered in Palo Alto, CA.

Quotient Sciences Ltd. provides early stage drug development services. The firm offers formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industries. The company was founded in 1990 and is headquartered in Ruddington, the United Kingdom.

Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981.

Zeneca Pharmaceuticals manufactures medicines.

Ascot Midco 2 Ltd. engages in the research and experimental development on biotechnology. The company is headquartered in Birmingham, the United Kingdom.

Watch Bidco Ltd. functions as an investment holding British company. The private company is based in Ruddington, UK.

Part of Watch Topco Ltd., Watch Midco 1 Ltd. functions as an investment holding British company. The company is based in Ruddington, UK and was founded in 2015.